CME

Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying

Host: Carl Regillo, MD Guest: Jennifer I. Lim, MD, FARVO What are the...

• 0
• 0
• Ayer

Duchenne Muscular Dystrophy: Differentiating Advances in Treatment

Host: Omer Abdul Hamid, MD Guest: Nancy Kuntz, MD Guest: Migvis Monduy, MD...

• 0
• 0
• Ayer

GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical Expert Consensus on a New Target with...

Host: Jeffrey V. Matous, MD Guest: Donna Catamero, NP Guest: Ajai Chari, MD...

• 0
• 0
• Ayer

GET REAL: A Guide to Evolving Treatment of nAMD and DME Using Real-World Data

Host: Arshad M. Khanani, MD, MA Guest: Theodore Leng, MD, MS Let’s get real....

• 0
• 0
• 4 días

South Asians With IBD: Underrepresented and Underappreciated

Host: Tauseef Ali, MD, FACG, AGAF Host: Sabina Ali, MD Host: Neil Nandi, MD, FACP...

• 0
• 0
• 6 días

Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction in Patients with Early-Stage Melanoma

Host: Meghan Mooradian, MD This Patient Clinician Connection CME activity, led by Dr....

• 0
• 0
• 17 días

From Awareness to Action: What To Do With a Positive OSA Screen?

Host: Anne Marie Morse, DO, FAASM One billion people worldwide are estimated to have...

• 0
• 0
• 18 días

OSA: Exploring the Impact on Morbidity and Mortality

Host: Alcibiades J. Rodriguez, MD, FAASM One billion people worldwide are estimated...

• 0
• 0
• 18 días

Overcoming Hurdles: Effective OSA Screening in Primary Care

Host: Michael E. Yurcheshen, MD, FAASM One billion people worldwide are estimated to...

• 0
• 0
• 18 días

Pre-Operative Vigilance: The Role of OSA Screening in Surgical Safety

Host: Kevin Trice, MD One billion people worldwide are estimated to have Obstructive...

• 0
• 0
• 18 días

How to Screen for OSA

Host: Seema Khosla, MD, FCCP, FAASM One billion people worldwide are estimated to...

• 0
• 0
• 18 días

Extending Treatment Durability With Next-Generation Neovascular AMD Therapies

Guest: Durga Borkar, MD, MMCi Guest: Diana Do, MD Guest: Peter K. Kaiser, MD...

• 0
• 0
• 25 días

Quality Indicators: How Do You Compare? Part 1

Guest: Douglas Rex, MD Guest: Aasma Shaukat, MD, MPH In the battle against...

• 0
• 0
• 27 días

Quality Indicators: How Do You Compare? Part 2

Guest: Douglas Rex, MD In the battle against colorectal cancer, inadequate bowel...

• 0
• 0
• 27 días

Another Inadequate Bowel Prep? It May Not Be the Patient's Fault

Guest: Douglas Rex, MD In the battle against colorectal cancer, inadequate bowel...

• 0
• 0
• 27 días

Don't Flush Another Colonoscopy Down the Toilet

Guest: Douglas Rex, MD Guest: Aasma Shaukat, MD, MPH In the battle against...

• 0
• 0
• 27 días

Bowel Prep Hesitancy: What's It All About?

Guest: Aasma Shaukat, MD, MPH In the battle against colorectal cancer, inadequate...

• 0
• 0
• 27 días

New and Emerging Agents

In the battle against colorectal cancer, inadequate bowel preparation emerges as a critical...

• 0
• 0
• 27 días

Bowel Preparation Regimens: How Do They Compare?

Guest: Aasma Shaukat, MD, MPH In the battle against colorectal cancer, inadequate...

• 0
• 0
• 27 días

Patient Education: Telling Is Not Teaching and Listening Is Not Learning

Guest: Aasma Shaukat, MD, MPH In the battle against colorectal cancer, inadequate...

• 0
• 0
• 27 días